The purpose of this study was to measure out-of-field organ doses in clinical conditions in anthropomorphic paediatric phantoms which received a simulated treatment of a brain tumour with intensity modulated radiotherapy (IMRT) and 3D conformal radiotherapy (3D CRT). Organ doses measured with radiophotoluminescent and thermoluminescent dosemeters were on average 1.6 and 3.0 times higher for the 5 y-old than for the 10 y-old phantom for IMRT and 3D CRT, respectively. A larger 5-y to 10-y organ dose ratio for 3D CRT can be explained because the use of a mechanical wedge for the 5-y-old 3D CRT phantom treatment increased out-of-field doses. Due to different configurations of the radiation fields, for both phantoms, the IMRT technique resulted in a higher non-target brain dose and higher eye doses but lower thyroid doses compared to 3D CRT. For 3D CRT (which used a non-coplanar field configuration), eye doses were 3-6% and for IMRT (which used a coplanar field configuration) 27-30% of the treatment dose, respectively. For thyroid and more distant organs, doses were less than 1% of the treatment dose. Comparison of measured doses and doses calculated by the treatment planning system (TPS) showed that the TPS underestimated out-of-field doses both for IMRT and 3D CRT.

A concept of a multimodule multifiducial phantom has been introduced. Analytical framework has been developed to extract geometric characteristics of radiotherapy devices from projection images of a phantom. The phantom design and the methodology developed have been tested in simulations.

The aim of the study was to determine the relative biological effectiveness (RBE) of a 60-MeV proton radiotherapy beam at the Institute of Nuclear Physics, Polish Academy of Sciences (IFJ PAN) in Kraków, the first one to operate in Poland. RBE was assessed at the surviving fractions (SFs) of 0.01, 0.1, and 0.37, for normal human fibroblasts from three cancer patients. The cells were irradiated near the Bragg peak of the pristine beam and at three depths within a 28.4-mm spread-out Bragg peak (SOBP). Reference radiation was provided by 6-MV X-rays. The mean RBE value at SF = 0.01 for fibroblasts irradiated near the Bragg peak of pristine beam ranged between 1.06 and 1.15. The mean RBE values at SF = 0.01 for these cells exposed at depths of 2, 15, and 27 mm of the SOBP ranged between 0.95–1.00, 0.97–1.02, and 1.05–1.11, respectively. A trend was observed for RBE values to increase with survival level and with depth in the SOBP: at SF = 0.37 and at the depth of 27 mm, RBE values attained their maximum (1.19–1.24). The RBE values estimated at SF = 0.01 using normal human fibroblasts for the 60-MeV proton radiotherapy beam at the IFJ PAN in Kraków are close to values of 1.0 and 1.1, used in clinical practice.

The gamma index is a measure used routinely for the quality control of dose delivery in radiotherapy, implemented in commercial systems for the verification of treatment plans. It involves comparison of the difference between planned and delivered doses to a single reference. The same reference value is selected for all points in the plan that can potentially hide dose delivery errors, especially in medium and low dose areas. In this study, a receiver operating characteristic analysis is used to demonstrate the limits of the performance of the global gamma index as a method for detecting dose delivery errors. The performance of a global gamma index is compared with two approaches based on statistical tests for outlier detection. Two statistical approaches are considered: according to the first, the distribution of the delivered doses is estimated based on an appropriate calibration procedure. According to the second, the distribution of the delivered doses is estimated based on the detection of relatively homogeneous regions of a plan and analyzing the distributions of planned doses within these regions. The performance of the three approaches is compared based on analytical considerations and in simulations in which errors are intentionally introduced to the plan delivery and noise related to dose delivery is modeled. We have shown that a statistics-based approach to gamma analysis generally leads to better detection of true delivery errors. The results of analytical consideration coincide with the simulations. In simulations, we observe that both statistical approaches are better detectors of true delivery errors than the global method for the gamma-index passing rate in the range from 0.9–1.0. It is shown that the global gamma index is a weak detector of dose delivery errors, which in some circumstances behaves only slightly better than a purely random classifier.

Compared with 3D-CRT, the application of IMRT improves the dose distribution within the concave target volumes and reduces dose to the OAR structures without compromising target coverage.